A Colangite Esclerosante Primária (CEP) acomete cerca de 10 a 40 pessoas em um milhão no mundo todo, sendo mais comum nos homens, com idade média de 40 anos. Apesar da enfermidade não ter cura, existem tratamentos que podem proporcionar uma razoável qualidade de vida. Na quarta e última reportagem
CEPColangite Esclerosante PrimáriadoençafígadogastroenterologistaHospital Vera Cruz. José Carlos CoutoinflamaçãoMELDtransplanteum por cento Continue lendo »| Cookie | Duração | Descrição |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
